glp-1 telehealth crackdown news today Drugs, Digital Health & Obesity Trends in 2026 FEDS CRACK DOWN ON TELEHEALTH
Description
It affects 4-12% of patients [2]
Compared with LIXI, LIR is more effective in improving blood glucose and reducing weight, and both treatments are well tolerated (75, 77, 78)
The goal is to maintain the strength, function and resilience that allows you to age well and stay capable for the long run
But this is all very theoretical at this point
The problem is, some people don't make enough GLP-1, which might contribute to weight gain and obesity
